TY  - CONF 
AU  - Emperiale, V.
AU  - Sanchez-Piedra, C.
AU  - Cuende, E.
AU  - Vela-Casasempere, P.
AU  - Villegas, M. D. C.
AU  - Arija, S. M.
AU  - Fernandez, C. C.
AU  - del Pino, J.
AU  - POMBO SUAREZ, MANUEL ENRIQUE
AU  - Sanchez-Alonso, F.
AU  - Gómez-Reino Carnota, Juan Jesús
PY  - 2019
SN  - 0003-4967
UR  - http://hdl.handle.net/20.500.11940/15628
AB  - Background JAK inhibitors (JAKi) have been recently authorized in the European Union. JAKi long-term performance in the clinical practice setting still needs to be assessed. Drug survival reflects a drug’s effectiveness, safety, and tolerability;...
TI  - Survival of jak inhibitors: real-word data from the biobadaser III registry
DO  - 10.1136/annrheumdis-2019-eular.211
KW  - CHUS
VL  - 78
ER  -